Syndax Pharmaceuticals, Inc. SNDX
9.13 USD -0.32 (-3.36%)
As ofNov 16, 2026, 12:30 PM EST
9.07 Day range 9.48
9.07 52-week range 25.59
- YTD
- -56.53%
- 1 year
- -45.05%
SNDX revenue history
Revenue is income from the company’s ordinary business activities.
172,352,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 172,352,000 | 148,672,000 | 627.84% |
| FY 2024 | 2024-12-31 | 23,680,000 | 23,680,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | -139,709,000 | -100.00% |
| FY 2021 | 2021-12-31 | 139,709,000 | 138,192,000 | 9109.56% |
| FY 2020 | 2020-12-31 | 1,517,000 | 0 | 0.00% |
| FY 2019 | 2019-12-31 | 1,517,000 | 0 | 0.00% |
| FY 2018 | 2018-12-31 | 1,517,000 | -591,000 | -28.04% |
| FY 2017 | 2017-12-31 | 2,108,000 | 888,000 | 72.79% |
| FY 2016 | 2016-12-31 | 1,220,000 | 593,000 | 94.58% |
| FY 2015 | 2015-12-31 | 627,000 | 627,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:21.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
